Agenda

Europe (1) - Building Patents at the EPO That Can Withstand Downstream Scrutiny at the UPC

Europe (2) - Second Medical Use Litigation: Navigating Enforcement and Validity Challenges

Europe (3) - Commercialising Generic Medicines in Europe: Managing Patent and Litigation Risk

The Netherlands - Reviewing the Role of Dutch Proceedings In Cross-Border Patent Disputes

Poland - Dapagliflozin and the Future of Pharmaceutical Patent Litigation in Poland

UK - Latest UK SPCs Case Law and Unresolved Questions Under the SPC Framework

USA - 505(b)(2) Pathway on the Rise: Balancing Litigation Risks Against Market Opportunities

China - Understanding the Interaction Between RDP, PTE and Patent Linkage Frameworks

Global (1) - Bridging Patent Prosecution and Litigation Strategy for AI-Discovered Therapeutics

Global (2) - Minimising Dispute Risk for AI and Machine Learning Collaborations